Literature DB >> 27075671

Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.

Siarhei Kharytonchyk1, Steven R King1, Clement B Ndongmo1, Krista L Stilger1, Wenfeng An1, Alice Telesnitsky2.   

Abstract

A key contributor to HIV-1 genetic variation is reverse transcriptase errors. Some mutations result because reverse transcriptase (RT) lacks 3' to 5' proofreading exonuclease and can extend mismatches. However, RT also excises terminal nucleotides to a limited extent, and this activity contributes to AZT resistance. Because HIV-1 mismatch resolution has been studied in vitro but only indirectly during replication, we developed a novel system to study mismatched base pair resolution during HIV-1 replication in cultured cells using vectors that force template switching at defined locations. These vectors generated mismatched reverse transcription intermediates, with proviral products diagnostic of mismatch resolution mechanisms. Outcomes for wild-type (WT) RT and an AZT-resistant (AZT(R)) RT containing a thymidine analog mutation set-D67N, K70R, D215F, and K219Q-were compared. AZT(R) RT did not excise terminal nucleotides more frequently than WT, and for the majority of tested mismatches, both WT and AZT(R) RTs extended mismatches in more than 90% of proviruses. However, striking enzyme-specific differences were observed for one mispair, with WT RT preferentially resolving dC-rC pairs either by excising the mismatched base or switching templates prematurely, while AZT(R) RT primarily misaligned the primer strand, causing deletions via dislocation mutagenesis. Overall, the results confirmed HIV-1 RT's high capacity for mismatch extension during virus replication and revealed dramatic differences in aberrant intermediate resolution repertoires between WT and AZT(R) RTs on one mismatched replication intermediate. Correlating mismatch extension frequencies observed here with reported viral mutation rates suggests a complex interplay of nucleotide discrimination and mismatch extension drives HIV-1 mutagenesis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  forced copy-choice recombination; retroviral error mechanisms

Mesh:

Substances:

Year:  2016        PMID: 27075671      PMCID: PMC4884515          DOI: 10.1016/j.jmb.2016.04.005

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  72 in total

1.  Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis.

Authors:  Patrick K O'Neil; Guoli Sun; Hong Yu; Yacov Ron; Joseph P Dougherty; Bradley D Preston
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

2.  Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.

Authors:  Michael E Abram; Andrea L Ferris; Kalyan Das; Octavio Quinoñes; Wei Shao; Steven Tuske; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

3.  Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate.

Authors:  J G Julias; V K Pathak
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

4.  The fidelity of 3' misinsertion and mispair extension during DNA synthesis exhibited by two drug-resistant mutants of the reverse transcriptase of human immunodeficiency virus type 1 with Leu74-->Val and Glu89-->Gly.

Authors:  T Rubinek; M Bakhanashvili; R Taube; O Avidan; A Hizi
Journal:  Eur J Biochem       Date:  1997-07-01

5.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  Lys66 residue as a determinant of high mismatch extension and misinsertion rates of HIV-1 reverse transcriptase.

Authors:  Chisanga Lwatula; Scott J Garforth; Vinayaka R Prasad
Journal:  FEBS J       Date:  2012-09-27       Impact factor: 5.542

Review 7.  Intracellular nucleotide levels and the control of retroviral infections.

Authors:  Sarah M Amie; Erin Noble; Baek Kim
Journal:  Virology       Date:  2012-12-20       Impact factor: 3.616

8.  Mutation rates and intrinsic fidelity of retroviral reverse transcriptases.

Authors:  Luis Menéndez-Arias
Journal:  Viruses       Date:  2009-12-04       Impact factor: 5.048

9.  The HIV-1 Rev protein enhances encapsidation of unspliced and spliced, RRE-containing lentiviral vector RNA.

Authors:  Bastian Grewe; Katrin Ehrhardt; Bianca Hoffmann; Maik Blissenbach; Sabine Brandt; Klaus Uberla
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

10.  Mismatch extension during strong stop strand transfer and minimal homology requirements for replicative template switching during Moloney murine leukemia virus replication.

Authors:  Sharon Fodor Marr; Alice Telesnitsky
Journal:  J Mol Biol       Date:  2003-07-18       Impact factor: 5.469

View more
  3 in total

Review 1.  Molecular Docking Studies of HIV-1 Resistance to Reverse Transcriptase Inhibitors: Mini-Review.

Authors:  Olga Tarasova; Vladimir Poroikov; Alexander Veselovsky
Journal:  Molecules       Date:  2018-05-21       Impact factor: 4.411

2.  Bimodal Expression Patterns, and Not Viral Burst Sizes, Predict the Effects of Vpr on HIV-1 Proviral Populations in Jurkat Cells.

Authors:  Edmond Atindaana; Abena Kissi-Twum; Sarah Emery; Cleo Burnett; Jake Pitcher; Myra Visser; Jeffrey M Kidd; Alice Telesnitsky
Journal:  mBio       Date:  2022-04-06       Impact factor: 7.786

3.  Stable integrant-specific differences in bimodal HIV-1 expression patterns revealed by high-throughput analysis.

Authors:  David F Read; Edmond Atindaana; Kalyani Pyaram; Feng Yang; Sarah Emery; Anna Cheong; Katherine R Nakama; Cleo Burnett; Erin T Larragoite; Emilie Battivelli; Eric Verdin; Vicente Planelles; Cheong-Hee Chang; Alice Telesnitsky; Jeffrey M Kidd
Journal:  PLoS Pathog       Date:  2019-10-04       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.